114873-08-4 Usage
Uses
Used in Pharmaceutical Industry:
BOC-5-CHLORO-L-TRYPTOPHAN is used as a building block for the synthesis of various pharmaceuticals, leveraging its unique structural features to create novel compounds with potential therapeutic applications. Its role in the development of new drugs is significant due to its ability to impart distinct properties to the synthesized molecules.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, BOC-5-CHLORO-L-TRYPTOPHAN serves as a valuable tool for research, enabling scientists to explore its altered properties and investigate its potential in the treatment of various diseases. Its modified structure allows for the design and synthesis of compounds with improved pharmacological profiles.
Used in Peptide Synthesis:
BOC-5-CHLORO-L-TRYPTOPHAN is utilized as a key component in peptide synthesis, where its protected amino group facilitates the stepwise assembly of peptide chains. The Boc group serves to prevent unwanted side reactions during synthesis, ensuring the production of the desired peptide sequences with high purity and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 114873-08-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,8,7 and 3 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 114873-08:
(8*1)+(7*1)+(6*4)+(5*8)+(4*7)+(3*3)+(2*0)+(1*8)=124
124 % 10 = 4
So 114873-08-4 is a valid CAS Registry Number.
InChI:InChI=1/C16H19ClN2O4/c1-16(2,3)23-15(22)19-13(14(20)21)6-9-8-18-12-5-4-10(17)7-11(9)12/h4-5,7-8,13,18H,6H2,1-3H3,(H,19,22)(H,20,21)/t13-/m0/s1
114873-08-4Relevant academic research and scientific papers
Identification of potent non-peptide somatostatin antagonists with sst3 selectivity
Poitout,Roubert,Contour-Galcéra,Moinet,Lannoy,Pommier,Plas,Bigg,Thurieau
, p. 2990 - 3000 (2007/10/03)
Using a solution-phase parallel synthesis strategy, a series of non-peptide somatostatin analogues were prepared, and their binding affinities to the five human somatostatin receptor subtypes (sst1-5) were determined. Imidazolyl derivatives 2 w